Remove 2026 Remove Patients Remove Treatment
article thumbnail

Laser focus boosting athletic performance with low-level laser therapy

Chiropractic Economics

This is a fundamental change in the clinical toolbox that will allow healthcare providers to deliver a higher level of service and enhanced clinical outcomes to their patient populations. We can’t wait to see what he does in 2026. as quickly as possible. during the 2012 Summer Olympics in London in 2012.

Ligaments 264
article thumbnail

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

OrthoSpineNews

The designation covers the use of the therapeutic medical device to treat patients who continue to experience knee pain or impairment following a meniscus surgery, which impacts approximately 250,000 Americans annually. ” OrthoPreserve hopes to launch their Pilot clinical trial in 2026, while aiming for potential FDA approval by 2029.